ClinicalTrials.Veeva

Menu
C

Centrum Medyczne KERmed | Dermatology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Lorcaserin HCl
BELVIQ
Apixaban
Vancomycin
Etripamil
OP1

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 6 total trials

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

Rationale: Allergic rhinitis/rhinoconjunctivitis (ARC) is a global health problem, affecting 10-25% of the population. Allergen-specific immunotherap...

Active, not recruiting
House Dust Mite Rhinitis
House Dust Mite Allergy
Biological: PURETHAL Mites 50,000 AUeq/ml
Biological: Biological/Vaccine: Placebo

Trial sponsors

A
Bayer logo
Eisai logo
H
M
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems